CB-Exo-A600
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CB-Exo-A600, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]